頸椎症の診断と治療市場- 世界の産業規模、シェア、動向、機会、予測、診断別、製品タイプ別、流通チャネル別、地域別、競合別、2020～2030年

頸椎症の診断と治療の世界市場規模は2024年に64億3,000万米ドルで、予測期間中のCAGRは6.72%で2030年には95億2,000万米ドルに達すると予測されています。

頸椎症の診断と治療の世界市場は、特に高齢化社会と座りっぱなしのライフスタイルの人々の間で、頸椎症の有病率が上昇していることが主な要因です。MRIやCTスキャンなどの診断技術の進歩と相まって、この疾患に対する認識が高まり、早期発見と治療成績が向上しています。理学療法、薬物療法、低侵襲手術などの非侵襲的治療オプションに対する需要の高まりが、市場拡大に寄与しています。高度な手術手技の開発と術後ケアの改善が、治療効果と患者の回復を高めています。生物製剤と再生医療における革新は、個別化ヘルスケアへの注目の高まりとともに、頸椎症に対するより的を絞った効果的な治療選択肢を提供することで、市場の成長を促進すると予想されます。

市場促進要因

頸椎症の有病率の増加

主な市場課題

高い治療費

主要市場動向

再生医療への注目の高まり

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の頸椎症の診断と治療市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 診断別（画像検査、頸部X線、MRI、CT脊髄造影検査、神経機能検査、筋電図検査、神経伝導検査）
  • 製品タイプ別（医薬品、医療機器、手術器具）
  • 流通チャネル別（病院薬局、小売薬局、オンライン薬局）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米の頸椎症の診断と治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の頸椎症の診断と治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域の頸椎症の診断と治療市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の頸椎症の診断と治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの頸椎症の診断と治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収（ある場合）
• 製品の発売（ある場合）
• 最近の動向

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Novartis AG
• Merck & Co. Inc.
• Bayer AG
• Abbott Laboratories Inc.
• Ortho Bracing
• Medtronic Plc
• Stryker Corporation
• B. Braun SE
• DJO, LLC
• Aspen Medical Products, LLC

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Cervical Spondylosis Diagnosis And Treatment Market was valued at USD 6.43 Billion in 2024 and is expected to reach USD 9.52 Billion by 2030 with a CAGR of 6.72% during the forecast period. The global cervical spondylosis diagnosis and treatment market is primarily driven by the rising prevalence of cervical spondylosis, particularly among the aging population and individuals with sedentary lifestyles. Increased awareness of the condition, coupled with advances in diagnostic technologies such as MRI and CT scans, has improved early detection and treatment outcomes. The growing demand for non-invasive treatment options, including physical therapy, medications, and minimally invasive surgeries, is contributing to market expansion. The development of advanced surgical techniques and improved post-operative care are enhancing treatment effectiveness and patient recovery. Innovations in biologics and regenerative medicine, along with an increasing focus on personalized healthcare, are expected to fuel growth in the market by providing more targeted and effective treatment options for cervical spondylosis.

Key Market Drivers

Increasing Prevalence of Cervical Spondylosis

The rising prevalence of cervical spondylosis is one of the primary factors driving the global market. Cervical spondylosis is more common in individuals over the age of 40, with its incidence increasing with age due to the natural wear and tear of the cervical spine. As global life expectancy rises, the elderly population is expected to grow significantly, contributing to a higher number of cervical spondylosis cases. Most individuals with spondylotic changes in the cervical spine, as seen on radiographic imaging, remain asymptomatic. However, approximately 25% of those under the age of 40, 50% of individuals over 40, and 85% of people over 60 show signs of degenerative changes. The most commonly affected vertebral levels are C6-C7, followed by C5-C6. Symptomatic cervical spondylosis typically manifests as neck pain. In the general population, the point prevalence of neck pain ranges from 0.4% to 41.5%, the 1-year incidence ranges from 4.8% to 79.5%, and lifetime prevalence can be as high as 86.8%.

Key Market Challenges

High Treatment Costs

One of the primary challenges in the cervical spondylosis diagnosis and treatment market is the high cost of treatment. Advanced diagnostic techniques such as MRI and CT scans, as well as sophisticated surgical interventions, can be prohibitively expensive, especially in low and middle-income countries. Minimally invasive surgeries, stem cell therapies, and other innovative treatment options, while highly effective, are often costly and may not be affordable for many patients. The high treatment costs place a significant burden on healthcare systems, patients, and insurance providers. Even in regions with robust healthcare infrastructure, the financial strain on patients can deter them from seeking timely treatment, which could lead to worsened health outcomes. This economic barrier to access is a challenge that hinders broader adoption of advanced treatments, especially in developing regions.

Key Market Trends

Rising Focus on Regenerative Medicine

Regenerative medicine is an emerging field that is driving significant growth in the cervical spondylosis market. This field includes the use of biologics such as stem cell therapy, platelet-rich plasma (PRP) injections, and growth factor therapies, all of which are being explored as potential treatments for cervical spondylosis. Stem cell therapy, in particular, holds great promise for patients with severe disc degeneration by promoting the regeneration of damaged tissues and encouraging the healing of spinal discs. PRP therapy involves the use of a patient's own blood platelets to promote healing and reduce inflammation in the affected cervical area. Regenerative medicine offers a more natural and minimally invasive alternative to traditional surgery, providing new hope for patients who are not candidates for more invasive procedures. As research and clinical trials continue to explore the efficacy of these treatments, regenerative medicine is expected to play an increasingly important role in managing cervical spondylosis, driving the demand for related therapies and treatments in the global market.

Key Market Players

• Novartis AG
• Merck & Co. Inc.
• Bayer AG
• Abbott Laboratories Inc.
• Ortho Bracing
• Medtronic Plc
• Stryker Corporation
• B. Braun SE
• DJO, LLC
• Aspen Medical Products, LLC

Report Scope:

In this report, the Global Cervical Spondylosis Diagnosis And Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cervical Spondylosis Diagnosis And Treatment Market, By Diagnosis:

• Imaging Tests
• Neck X-ray
• MRI
• CT Myelography
• Nerve Function Tests
• Electromyography
• Nerve Conduction Study

Cervical Spondylosis Diagnosis And Treatment Market, By Product Type:

• Medications
• Medical Devices
• Surgical Instruments

Cervical Spondylosis Diagnosis And Treatment Market, By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Cervical Spondylosis Diagnosis And Treatment Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cervical Spondylosis Diagnosis And Treatment Market.

Available Customizations:

Global Cervical Spondylosis Diagnosis And Treatment market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cervical Spondylosis Diagnosis And Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Diagnosis (Imaging Tests, Neck X-ray, MRI, CT Myelography, Nerve Function Tests, Electromyography, and Nerve Conduction Study)
  • 5.2.2. By Product Type (Medications, Medical Devices, and Surgical Instruments)
  • 5.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Cervical Spondylosis Diagnosis And Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Diagnosis
  • 6.2.2. By Product Type
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cervical Spondylosis Diagnosis And Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Diagnosis
      • 6.3.1.2.2. By Product Type
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Canada Cervical Spondylosis Diagnosis And Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Diagnosis
      • 6.3.2.2.2. By Product Type
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Mexico Cervical Spondylosis Diagnosis And Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Diagnosis
      • 6.3.3.2.2. By Product Type
      • 6.3.3.2.3. By Distribution Channel

7. Europe Cervical Spondylosis Diagnosis And Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Diagnosis
  • 7.2.2. By Product Type
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Cervical Spondylosis Diagnosis And Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Diagnosis
      • 7.3.1.2.2. By Product Type
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. United Kingdom Cervical Spondylosis Diagnosis And Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Diagnosis
      • 7.3.2.2.2. By Product Type
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. Italy Cervical Spondylosis Diagnosis And Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Diagnosis
      • 7.3.3.2.2. By Product Type
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. France Cervical Spondylosis Diagnosis And Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Diagnosis
      • 7.3.4.2.2. By Product Type
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Cervical Spondylosis Diagnosis And Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Diagnosis
      • 7.3.5.2.2. By Product Type
      • 7.3.5.2.3. By Distribution Channel

8. Asia-Pacific Cervical Spondylosis Diagnosis And Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Diagnosis
  • 8.2.2. By Product Type
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Cervical Spondylosis Diagnosis And Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Diagnosis
      • 8.3.1.2.2. By Product Type
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. India Cervical Spondylosis Diagnosis And Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Diagnosis
      • 8.3.2.2.2. By Product Type
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Japan Cervical Spondylosis Diagnosis And Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Diagnosis
      • 8.3.3.2.2. By Product Type
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. South Korea Cervical Spondylosis Diagnosis And Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Diagnosis
      • 8.3.4.2.2. By Product Type
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. Australia Cervical Spondylosis Diagnosis And Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Diagnosis
      • 8.3.5.2.2. By Product Type
      • 8.3.5.2.3. By Distribution Channel

9. South America Cervical Spondylosis Diagnosis And Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Diagnosis
  • 9.2.2. By Product Type
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Cervical Spondylosis Diagnosis And Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Diagnosis
      • 9.3.1.2.2. By Product Type
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. Argentina Cervical Spondylosis Diagnosis And Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Diagnosis
      • 9.3.2.2.2. By Product Type
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. Colombia Cervical Spondylosis Diagnosis And Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Diagnosis
      • 9.3.3.2.2. By Product Type
      • 9.3.3.2.3. By Distribution Channel

10. Middle East and Africa Cervical Spondylosis Diagnosis And Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Diagnosis
  • 10.2.2. By Product Type
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Cervical Spondylosis Diagnosis And Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Diagnosis
      • 10.3.1.2.2. By Product Type
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Saudi Arabia Cervical Spondylosis Diagnosis And Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Diagnosis
      • 10.3.2.2.2. By Product Type
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. UAE Cervical Spondylosis Diagnosis And Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Diagnosis
      • 10.3.3.2.2. By Product Type
      • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Novartis AG
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Merck & Co. Inc.
• 14.3. Bayer AG
• 14.4. Abbott Laboratories Inc.
• 14.5. Ortho Bracing
• 14.6. Medtronic Plc
• 14.7. Stryker Corporation
• 14.8. B. Braun SE
• 14.9. DJO, LLC
• 14.10. Aspen Medical Products, LLC

15. Strategic Recommendations

16. About Us & Disclaimer